BTIG Downgrades Neogenomics (NEO) to Neutral

September 11, 2017 7:13 AM EDT Send to a Friend
BTIG downgraded Neogenomics (NASDAQ: NEO) from Buy to Neutral.Analyst Sean Lavin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login